Jardiance
Generic Name: jardiance
Dosage form: POWDER. Active ingredients: EMPAGLIFLOZIN (25 mg/25mg). Category: DRUG FOR FURTHER PROCESSING.
Overview
Dosage form: POWDER. Active ingredients: EMPAGLIFLOZIN (25 mg/25mg). Category: DRUG FOR FURTHER PROCESSING.
Dosage
Available as powder.
Related Medications
Amlodipine Besylate And Olmesartran Medoxomil
amlodipine besylate and olmesartran medoxomil
11 DESCRIPTION Amlodipine and olmesartan medoxomil provided as a tablet for oral administration, is a combination of the calcium channel blocker (CCB) amlodipine besylate and the angiotensin II receptor blocker (ARB) olmesartan medoxomil. The amlodipine besylate, USP component of amlodipine and olmesartan medoxomil tablet, USP is chemically described as 3-ethyl-5-methyl (±)-2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl- 3,5pyridinedicarboxylate, monobenzenesulphonate.
Methylphenidate
methylphenidate
Central Nervous System Stimulant [EPC]
11 DESCRIPTION Methylphenidate transdermal system is an adhesive-based matrix transdermal system containing methylphenidate that is applied to intact skin. The chemical name for methylphenidate is α-phenyl-2-piperidineacetic acid methyl ester. It is a white to off-white powder and is soluble in alcohol, ethyl acetate, and ether. Methylphenidate is practically insoluble in water and petrol ether. Its molecular weight is 233.31. Its empirical formula is C 14 H 19 NO 2 .
Technetium Tc-99m Pyrophosphate Kit
technetium tc-99m pyrophosphate kit
Manufactured by BRACCO. Dosage form: INJECTABLE. Route: INJECTION. Active ingredients: TECHNETIUM TC-99M PYROPHOSPHATE KIT (N/A). Application: NDA017680.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.